3rd interview







Re: Was 3rd now 4th interview...

The drugs are not on the same class moron, one is a bisphosphonate and the other is a monoclonal antibidy..you dont know what youre talking about

You are the idiot, and miss the point. The bottomline is that they are both infusion drugs indicated for the treatment of osteoperosis (boniva also had a pill). While the mode of action may be different; they treat the same exact condition, and are delivered via infusion. They are bot "buy and bill", etc.

So I make my point again, In one instance the infusion drug was "sold" by primary care reps, and in another case a different infusion drug for Osteoperosis is "sold" by so called superior "specialty" biotech reps; the bottomnline is that there is no difference.

I will end by quoting the person who was the head of Genetech CTandD about four years ago, when she told a room full of GEM candidates that "any primary care rep can be trained to cell Oncology products, etc and be very productive in 6 months." The bottomline, is a rep is a rep, and can sell whatever product they happened to be trained to sell.

I know of several people who transferred to oncology sales at genentech and all are succeeding with no issues.
 






Re: Was 3rd now 4th interview...

You are the idiot, and miss the point. The bottomline is that they are both infusion drugs indicated for the treatment of osteoperosis (boniva also had a pill). While the mode of action may be different; they treat the same exact condition, and are delivered via infusion. They are bot "buy and bill", etc.

So I make my point again, In one instance the infusion drug was "sold" by primary care reps, and in another case a different infusion drug for Osteoperosis is "sold" by so called superior "specialty" biotech reps; the bottomnline is that there is no difference.

I will end by quoting the person who was the head of Genetech CTandD about four years ago, when she told a room full of GEM candidates that "any primary care rep can be trained to cell Oncology products, etc and be very productive in 6 months." The bottomline, is a rep is a rep, and can sell whatever product they happened to be trained to sell.

I know of several people who transferred to oncology sales at genentech and all are succeeding with no issues.

I agree with this post, the challenge is the hiring management, many of whom believe one must be a vetted oncology specialist with years of experience and "relationships" who will give the non-oncology reps a courtesy sniff but who have no intentions of ever extending an offer. Just stating the obvious.
 






Re: Was 3rd now 4th interview...

I agree with this post, the challenge is the hiring management, many of whom believe one must be a vetted oncology specialist with years of experience and "relationships" who will give the non-oncology reps a courtesy sniff but who have no intentions of ever extending an offer. Just stating the obvious.

I do think that it makes sense that if you sell HCV drugs, you would prefer an existing HCV rep that perhaps has worked in the territory that you are trying to fill; this makes sense for Onlcology, HCV, Diabetes, whatever. What doesnt make sense is feeling that there are different levels of Drug reps depending on what they sell. The thought that a non-oncology "specialty/Biotech" rep is more likely to succeed in Oncology than a primary care rep is silly. The bottomline is that "a rep is a rep". You are all trained to sell a product (s), and the overwhelming majority have no issues, as it pertains to product and disease knowledge.
 






Re: Was 3rd now 4th interview...

You are the idiot, and miss the point. The bottomline is that they are both infusion drugs indicated for the treatment of osteoperosis (boniva also had a pill). While the mode of action may be different; they treat the same exact condition, and are delivered via infusion. They are bot "buy and bill", etc.

So I make my point again, In one instance the infusion drug was "sold" by primary care reps, and in another case a different infusion drug for Osteoperosis is "sold" by so called superior "specialty" biotech reps; the bottomnline is that there is no difference.

I will end by quoting the person who was the head of Genetech CTandD about four years ago, when she told a room full of GEM candidates that "any primary care rep can be trained to cell Oncology products, etc and be very productive in 6 months." The bottomline, is a rep is a rep, and can sell whatever product they happened to be trained to sell.

I know of several people who transferred to oncology sales at genentech and all are succeeding with no issues.

I sold Boniva Injection and Prolia. Same sale cycle. End of discussion.
 






Re: Was 3rd now 4th interview...

I sold Boniva Injection and Prolia. Same sale cycle. End of discussion.

I am looking at applying for the Avastin position in Iowa. Sounds like the rep got promoted. Is it a good territory for Genentech? Like the Lung Cancer arena. Thx for any insight and information. Heard Genentech pays 130-150k for starting wages.
 






Re: Was 3rd now 4th interview...

I am looking at applying for the Avastin position in Iowa. Sounds like the rep got promoted. Is it a good territory for Genentech? Like the Lung Cancer arena. Thx for any insight and information. Heard Genentech pays 130-150k for starting wages.

You herd wrong. Why don't you call up the hiring manager and demand that kind of money!
 












Re: Was 3rd now 4th interview...

You herd wrong. Why don't you call up the hiring manager and demand that kind of money!

The manager is a big player within Genentech. If he needs to put out 160k in base he can probably get it.

The rep in Iowa got promoted, a large share of the calls were fake. Heck, putting in calls on physicians with a pulse may be optional. Cherry job for sure. Lots of vacation and gym time. Slam dunk for someone. Almost like collecting a pension. The manager has you covered.